Exploratory Study of Breast Cancer With ABY025
The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.
Breast Cancer
DRUG: 111-In-ABY-025
Imaging of metastases, Imaging of breast cancer metastases using 111-In-ABY015 for SPECT, One year
Can the new molecule be used for imaging in extended studies, October 2010 - June 2011
The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.